(Q45958408)

18 December 2017

title

Rapid normalization of portopulmonary hypertension after living donor liver transplantation. (English)

1 reference

18 December 2017

main subject

liver transplantation

1 reference

K Sugimachi

1

1 reference

18 December 2017

Y Soejima

2

1 reference

18 December 2017

K Morita

3

1 reference

18 December 2017

S Ueda

4

1 reference

18 December 2017

T Fukuhara

5

1 reference

18 December 2017

S Nagata

6

1 reference

18 December 2017

T Ikegami

7

1 reference

18 December 2017

A Taketomi

8

1 reference

18 December 2017

Y Maehara

9

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

18 December 2017

Transplantation Proceedings

published in

1 reference

18 December 2017

volume

41

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

1976-1978

1 reference

18 December 2017

Portopulmonary hypertension and hepatopulmonary syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Normal hepatic hemodynamics during early postoperative period in recipients with adult live donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Severe pulmonary hypertension in liver transplant candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

De novo diagnosis of portopulmonary hypertension following liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.02.095

10.1016/J.TRANSPROCEED.2009.02.095

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017